William Blair & Company’s CONMED CNMD Stock Holding History

William Blair & Company’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-387,266	Closed	-$22.6M	–	1426
2015 Q2	$22.6M	Buy	387,266 +21,420	+6%	+$1.15M	0.03%	596
2015 Q1	$18.5M	Buy	365,846 +4,955	+1%	+$243K	0.03%	632
2014 Q4	$16.2M	Buy	360,891 +18,236	+5%	+$764K	0.03%	664
2014 Q3	$12.6M	Buy	342,655 +3,514	+1%	+$139K	0.02%	757
2014 Q2	$15M	Sell	339,141 -19,390	-5%	-$879K	0.02%	690
2014 Q1	$15.6M	Buy	358,531 +52,113	+17%	+$2.32M	0.03%	662
2013 Q4	$13M	Buy	306,418 +31,394	+11%	+$1.19M	0.02%	712
2013 Q3	$9.34M	Buy	275,024 +5,885	+2%	+$192K	0.02%	762
2013 Q2	$8.41M	Buy	+269,139	New	+$8.73M	0.02%	773

Other funds holding CNMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Coppersmith Capital Management New York $105M AUM 8.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

William Blair & Company's CNMD Position: Q3 2015 in Review

William Blair & Company sold out of CONMED (CNMD) in Q3 2015, closing a stake of 387,266 shares — an estimated $22.6M sold.

William Blair & Company first reported a position in CNMD in Q2 2013 and held it in 9 quarters. The position peaked at $22.6M in Q2 2015. 157 funds tracked by Wall St. Rank hold CNMD as of Q3 2015.

William Blair & Company reported no remaining CONMED position as of Q3 2015 after selling out during the quarter.
William Blair & Company sold 387,266 CONMED shares in Q3 2015, an estimated $22.6M.
William Blair & Company first reported a position in CONMED in Q2 2013 and held it in 9 quarters.
William Blair & Company's CONMED position peaked at $22.6M in Q2 2015.
157 funds tracked by Wall St. Rank held CONMED as of Q3 2015.

Based on William Blair & Company's 13F filing for Q3 2015, filed 12 Nov 2015.